Clinigen shares drop 10% after earnings downgrade
Shares in specialist pharmaceutical products and services group Clinigen (CLIN:AIM) sank 10% to 629.5p on Thursday after the company downgraded its full year profit expectations for 2022.Lower than anticipated sales of Clinigen's...
16 September 2021